Can regorafenib be used with grapefruit products?

Regorafenib is a multi-target tyrosine kinase inhibitor that is widely used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. However, certain dietary components may interfere with the pharmacokinetics of regorafenib during use, particularly grapefruit and its products. Grapefruit is rich in a natural substance called furanocoumarins, which strongly inhibits the activity of CYP3A4, a key drug metabolizing enzyme in the liver. Regorafenib is mainly metabolized through the CYP3A4 pathway. Therefore, if grapefruit juice is taken at the same time, it may significantly increase the blood concentration, thereby enhancing drug toxicity and leading to aggravation of adverse reactions, such as an increased incidence of side effects such as hand-foot syndrome, abnormal liver function, hypertension, and fatigue.

Multiple medical pharmacopeias and drug instructions indicate that patients should avoid ingesting grapefruit, grapefruit juice and related extracts while taking regorafenib. This dietary taboo applies not only to fruit prototypes, but also to health products, drinks and even some flavored foods based on grapefruit. Although the problems that arise in individual cases may vary from person to person, clinical guidance generally adopts a conservative strategy of completely avoiding such foods to prevent increased drug toxicity.

In addition, attention should be paid to other foods or drugs that may affect theCYP3A4 metabolism system, such as herbal preparations such as St. John's wort, which may also cause fluctuations in drug efficacy, or even reduce or be too strong. Therefore, doctors usually include dietary guidance in the prescription instructions for regorafenib to help patients avoid risks. For patients taking medicine for a long time, blood pressure, liver enzymes and drug tolerance should also be monitored regularly, and dosage adjustments should be made if necessary to ensure the safety and continuity of treatment.

In summary, in order to ensure the therapeutic effect and safety, the intake of grapefruit-related foods and drinks should be strictly avoided during the use of regorafenib.

Reference materials:https://www.stivarga-us.com/